Pharma Mar, S.A.
MSE:PHM.MC
68.75 (EUR) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Pharma Mar, S.A. |
Symbool | PHM.MC |
Munteenheid | EUR |
Prijs | 68.75 |
Beurswaarde | 1,226,438,125 |
Dividendpercentage | 1.84% |
52-weken bereik | 26.16 - 70.25 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jose Maria Fernandez Sousa-Faro Ph.D. |
Website | https://www.pharmamar.com |
An error occurred while fetching data.
Over Pharma Mar, S.A.
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)